Sebaceous carcinoma is an uncommon malignant neoplasm of the sebaceous glands, with an estimated incidence of 1 in 1,000,000 people per year. 1 The sebaceous glands are normally found in hair ...
(RTTNews) - Pulse Biosciences, Inc. (PLSE), a bioelectric medicine company, has received FDA clearance for its CellFX System to expand the indication for use in the treatment of sebaceous hyperplasia ...
HAYWARD, Calif.--(BUSINESS WIRE)-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company developing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, ...